Fight About Fees Unites Foes

File PhotoAboycott over the high price of online access to scientific journals has turned into a rolling protest with faculty and administrators, for once, on the same side of a budget battle.By last month, Harvard University, Cornell University, Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill had all joined the movement that started in 2003 at the University of California, San Francisco. The schools' faculty took a hard line in contract nego

Written byPeg Brickley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

File Photo

Aboycott over the high price of online access to scientific journals has turned into a rolling protest with faculty and administrators, for once, on the same side of a budget battle.

By last month, Harvard University, Cornell University, Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill had all joined the movement that started in 2003 at the University of California, San Francisco. The schools' faculty took a hard line in contract negotiations with Elsevier, the Amsterdam-based publisher of hundreds of life sciences journals.

An Elsevier spokesman counters that US scientists are naïve in their assessment of the financial realities of scientific publishing. "We have volume discounts and special introductory offers and they come to an end, and people find that difficult to comprehend," says Eric Merkel-Sobotta, Elsevier spokesman.

Elsevier is the science publishing division of Reed Elsevier, which posted €219 million ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies